Skip to content

Korean Version of the Quality of Recovery 15 After General Anesthesia

Validation and Clinical Implications of the Korean Version of the Quality of Recovery 15 After General Anesthesia: A Prospective Observational Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04169087
Enrollment
200
Registered
2019-11-19
Start date
2019-11-19
Completion date
2020-06-22
Last updated
2020-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Complications

Brief summary

The aim of this study is to test the Korean version of QoR-15 for its validity and clinical acceptability and feasibility.

Detailed description

Quality of recovery (QoR) after anesthesia is an important measure of the early postoperative health status of patients. The QoR-40 is a widely-used questionnaire for postoperative patients and the short-form version of it (QoR-15) was developed in 2013. The validation of QoR-15 has been reported in the version of English, Portuguese, Danish, Chinese and Swedish. However, the study to validate the Korean version of QoR-15 has not been demonstrated. Patients undergoing surgery and general anesthesia are asked by the investigators to complete the QoR-15 questionnaire and Korean 36-Item Short Form Health Survey (SF-36) a day before surgery. They are then asked to repeat the QoR-15 questionnaire 24 h postoperatively and also rate their overall postoperative pain score using 11-point numeric rating scale (NRS).

Interventions

OTHERQoR-15

The QoR-15 is the questionnaire to provide an evaluation of the postoperative quality of recovery. Patients undergoing surgery and general anesthesia are asked by the investigators to complete the QoR-15 questionnaire before and 24h after the surgery.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo elective general surgery, thoracic surgery and gynecological surgery under general anesthesia * Age between 18 and 80 years * Willingness and ability to sign an informed consent document * Ability to understand the contents of questionnaires

Exclusion criteria

* Age under 18 or over 80. * Do not understand our study * Medical or psychological disease that can affect the treatment response

Design outcomes

Primary

MeasureTime frameDescription
Convergent Validity of the QoR (Quality of Recovery)-1524 hours after the surgeryThe QoR-15 (0-150) is compared with the global QoR visual analog scale (VAS) (0-100), 36-Item Short Form Health Survey (SF-36) and interitem correlations are measured.
Construct Validity of the QoR (Quality of Recovery)-1524 hours after the surgeryTo investigate if there is an correlation between the QoR-15 (0-150) and age (yr), gender (male/female), American Society of Anesthesiologists (ASA) physical status (I-IV), type of surgery (minor/major), postoperative complication (Clavien Dindo grade II or high, %) and 11-point numeric rating scale (NRS) pain score.
Discriminant Validity of the QoR (Quality of Recovery)-1524 hours after the surgeryTo investigate if there is differences in the QoR-15 (0-150) and postoperative complications (Clavien Dindo grade II or high, %) between the high QoR score group and low QoR score group

Secondary

MeasureTime frameDescription
Reliability of the QoR (Quality of Recovery)-1524 hours after the surgeryCompare the two QoR-15 results measured at 60 minutes intervals using an intraclass correlation coefficient, and calculate the Cronbach alpha to investigate the internal consistency.
Response success rate of the QoR-15A day before and 24 hours after the surgeryDefined as success if the patient has answered all items.
Correlation of postoperative outcomes with QoR-1524 hours after the surgeryTo investigate if there is an correlation between the QoR-15 (0-150) at POD1 and length of hospital stay (day), postoperative complications (Clavien Dindo grade II or high, %), C-reactive protein (mg/L) at POD1, Granulocyte/lymphocyte ratio at POD1, readmission rate within 1 month

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026